Literature DB >> 25907706

Extra-CNS metastasis from glioblastoma: a rare clinical entity.

Musaddiq Awan1, Stanley Liu, Arjun Sahgal, Sunit Das, Samuel T Chao, Eric L Chang, Jonathan P S Knisely, Kristin Redmond, Jason W Sohn, Mitchell Machtay, Andrew E Sloan, David B Mansur, Lisa R Rogers, Simon S Lo.   

Abstract

Extra-CNS metastasis from glioblastoma (ECMGBM) is an emerging but little known clinical entity. We review pre-clinical and translational publications assessing the ability of GBM to spread locally and outside the CNS. Reported cases demonstrating ECMGBM are reviewed providing a summary of presentations for the entity. Special attention is placed on transmission of GBM through organ transplantation. Finally, predictions are made as to the future significance of ECMGBM, especially in the context of better outcomes in CNS GBM.

Entities:  

Keywords:  circulating tumor cells; glioblastoma; gliomas; malignancy in transplant patients; organ transplantation

Mesh:

Year:  2015        PMID: 25907706     DOI: 10.1586/14737140.2015.1028374

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  8 in total

1.  Secondary glioblastoma with abdominal metastasis: Case report.

Authors:  Ana María Granados; Natalia Zuñiga; Camila Ospina; Lina Merchancano
Journal:  Radiol Case Rep       Date:  2018-02-03

2.  SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma.

Authors:  Joseph H Choe; Payal B Watchmaker; Milos S Simic; Ryan D Gilbert; Aileen W Li; Nira A Krasnow; Kira M Downey; Wei Yu; Diego A Carrera; Anna Celli; Juhyun Cho; Jessica D Briones; Jason M Duecker; Yitzhar E Goretsky; Ruth Dannenfelser; Lia Cardarelli; Olga Troyanskaya; Sachdev S Sidhu; Kole T Roybal; Hideho Okada; Wendell A Lim
Journal:  Sci Transl Med       Date:  2021-04-28       Impact factor: 19.319

Review 3.  Harnessing the immune system in glioblastoma.

Authors:  Nicholas F Brown; Thomas J Carter; Diego Ottaviani; Paul Mulholland
Journal:  Br J Cancer       Date:  2018-11-05       Impact factor: 7.640

4.  NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.

Authors:  Haiwen Ma; Tao Li; Zhennan Tao; Long Hai; Luqing Tong; Li Yi; Iruni R Abeysekera; Peidong Liu; Yang Xie; Jiabo Li; Feng Yuan; Chen Zhang; Yihan Yang; Haolang Ming; Shengping Yu; Xuejun Yang
Journal:  J Cell Physiol       Date:  2018-08-29       Impact factor: 6.384

5.  DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance.

Authors:  Juliana Ferreira de Sousa; Rodolfo Bortolozo Serafim; Laura Marise de Freitas; Carla Raquel Fontana; Valeria Valente
Journal:  Genet Mol Biol       Date:  2019-12-13       Impact factor: 1.771

Review 6.  Cytology of Extraneural Metastases of Nonhematolymphoid Primary Central Nervous System Tumors: Six Cases with Histopathological Correlation and Literature Update.

Authors:  Joerg Schwock; Lorna Mirham; Zeina Ghorab
Journal:  Acta Cytol       Date:  2021-07-26       Impact factor: 2.319

7.  Osteosclerosis Secondary to Metastatic Oligodendroglioma.

Authors:  Patrick R Maloney; Vitor Nagai Yamaki; Ravi Kumar; Derek Johnson; Christopher Hunt; Mark E Jentoft; Michelle Clarke
Journal:  Rare Tumors       Date:  2017-03-31

8.  NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas.

Authors:  Huaiyu Sun; Shengrong Long; Bingbing Wu; Jia Liu; Guangyu Li
Journal:  PeerJ       Date:  2020-03-16       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.